| Pirtobrutinib+Sonrotoclax（PS) Regimen in the Treatment of B-Cell Lymphoma (NCT07744750) | Changzhou No.2 People's Hospital | 2026-08-30 |
| Pirtobrutinib+Pola-R-CHP for Newly Diagnosed Non-GCB DLBCL (NCT07744724) | Changzhou No.2 People's Hospital | 2026-07-31 |
| Pirtobrutinib + R-CHOP for Untreated Non-GCB DLBCL (NCT07744737) | Changzhou No.2 People's Hospital | 2026-07-30 |
| UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases (NCT06978738) | Changzhou No.2 People's Hospital | 2025-05-01 |
| An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune Thrombocytopenia (NCT06337474) | Changzhou No.2 People's Hospital | 2024-08-30 |
| γδ T-PD-1 Ab Cells in the Treatment of Advanced Solid Tumors (NCT06404281) | Changzhou No.2 People's Hospital | 2024-08-01 |
| FMT+Immunotherapy+Chemotherapy As First-line Treatment for Driver-gene Negative Advanced NSCLC (NCT06403111) | Changzhou No.2 People's Hospital | 2024-06-01 |
| FMT+SOX+Sintilimab As First-line Treatment for Advanced Gastric Cancer (NCT06405113) | Changzhou No.2 People's Hospital | 2024-06-01 |
| An Clinical Study of NKG2D-CAR-NK Cells for the Treatment of Refractory Recurrent Multiple Myeloma (NCT06379451) | Changzhou No.2 People's Hospital | 2024-04-18 |
| Effectiveness of Multimedia Health Education to Reduce Anxiety in Patients With Vitreous Floaters (NCT06964867) | Changzhou No.2 People's Hospital | 2023-12-01 |
| Effectiveness and Safety of 25-Gauge Needle-Assisted Phacoemulsification of Dislocated Intravitreal Lens Nucleus (NCT06709378) | Changzhou No.2 People's Hospital | 2022-07-01 |
| Apatinib Combined With S-1 in the Second-line Treatment of Advanced Pancreatic Cancer (NCT03662035) | Changzhou No.2 People's Hospital | 2018-09-15 |
| Phase II Trial of Thalidomide Combined With Concurrent Chemoradiotherapy in Esophageal Cancer (NCT01551641) | Changzhou No.2 People's Hospital | 2012-01-01 |